CD44 and neoplasm: Liu et al. showed that the SPP1–CD44 axis in hepatocellular carcinoma (HCC) leads to tumor progression, and that this axis could not be identified in the tumor-adjacent tissues of HCC, which is similar to the findings of our present study [45].